Fresenius SE & Co. KGaA is a Germany-based healthcare group focused on products and services for the treatment of critically and chronically ill patients. The Company operates through its core businesses, Fresenius Kabi and Fresenius Helios. Fresenius Kabi develops and supplies biopharmaceuticals, clinical nutrition products, medical technologies, intravenously administered generic drugs, and infusion therapies. Fresenius Helios is Europe’s private healthcare provider, operating hospitals, outpatient centers, and other healthcare facilities in Germany, Spain, and Latin America. Fresenius also holds an investment in Fresenius Medical Care, a provider of dialysis products and services for patients with chronic kidney disease.
Back to dashboard
Company Information
About this company
Key people
Wolfgang Kirsch
Independent Chairman of the Supervisory Board
Ralf Kiesslich
Independent Member of the Supervisory Board, Employee Representative
Iris Loew-Friedrich
Independent Member of the Supervisory Board
Susanne Zeidler
Independent Member of the Supervisory Board
Christoph Zindel
Independent Member of the Supervisory Board
Michael Sen
Chairman of the Management Board, Chief Executive Officer
Gerd Krick
Chairman of the Management Board
Michael Diekmann
Independent Deputy Chairman of the Supervisory Board
Grit Genster
Deputy Chairman of the Supervisory Board, Employee Representatives
Sara Hennicken
Chief Financial Officer, Member of the Management Board
Pierluigi Antonelli
Member of the Management Board, Chief Executive Officer - Fresenius Kabi
Robert Moeller
Member of the Management Board, Chief Executive Officer of Fresenius Helios
Michael Moser
Member of the Management Board, Legal, Compliance, Risk Management, Sustainability, Human Resources Corporate Audit and Vamed
Click to see more
Key facts
- Shares in issue563.24m
- EPICFRE
- ISINDE000FRE5EN2
- LocationGermany
- SectorHealthcare
- IndustryHealthcare Facilities
- Market cap€24.70bn
- Employees178,486
- ExchangeXETRA
- IndexDAX Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.